The Impact of the Novel Sodium-Dependent Glucose Cotransporter 2 Inhibitor, Enavogliflozin, on Cardiac Reverse Remodeling in Heart Failure Patients With Type 2 Diabetes Mellitus: A Case Series

Int J Heart Fail. 2024 Oct 28;6(4):176-178. doi: 10.36628/ijhf.2024.0018. eCollection 2024 Oct.

Authors

Taeil Yang¹, Youngwoo Jang^{2

3}, Wook-Jin Chung^{2

3}

Affiliations

¹ Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea.
² Gachon Cardiovascular Research Institute, Gachon University, Incheon, Korea.
³ Division of Cardiovascular Disease, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.

No abstract available